DWTX Dogwood Therapeutics, Inc. stock chart & analysis
Conviction 49HealthcareScan · Fri, Nov 20, 2026Dogwood Therapeutics, Inc. (DWTX) closed at $1.00 (-5.66%) on Nov 20, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 35, RS Rating 6, -85.8% from its 52-week high, -76.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Financials as of Wed, Sep 30, 2026 · quarterly.
DWTX technical analysis
Trend
DWTX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 23.4% below the 50-day ($1.31) and 45.6% below the 200-day ($1.84). ADX(14) at 16 points to a weak trend — more range than direction. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 35, in the bearish half of its range. The MACD histogram is positive. Its RS Rating of 6 puts its weighted 12-month performance ahead of about 6% of the US market.
Volume and volatility
Volume on the latest session ran 0.6× its 20-day average. It trades about $130,000 a day on average. ATR(14) is $0.1377, 13.8% of price — its typical daily range. Bollinger Bands are in a squeeze (11 sessions) — volatility is compressed. On-balance volume is trending down. Chaikin Money Flow (-0.24) shows distribution.
Key levels
The chart pattern's support is $0.9605 and its resistance $1.63. The 52-week range is $0.9010 to $7.04; price is 85.8% below the high and 11.0% above the low. The VWAP anchored at the 52-week high is $2.01, above price.
Performance
DWTX returned -9.9% (1 week), -10.7% (1 month), -60.9% (3 months), -44.1% (6 months), -83.3% (1 year), -76.0% (year to date).
About Dogwood Therapeutics, Inc.
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Pharmaceutical Preparations · Listed 2020 · 8 employees
Insider activity
SEC Form 4 transactions in DWTX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sealbond Ltd Director · Common Stock · 2026-10-26 | Grant | 4.1M | $5.0M | 2026-10-26 | 2026-10-27 |
SEC filings
EDGAR filings in DWTX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.